Nika Pharmaceuticals, Inc (NIKA): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

1.05B
Year ended 2025-12-31
+13.1%
3-year compound annual growth
2021-12-31: 396.09M2022-12-31: 723.95M2023-12-31: 876.09M2024-12-31: 1.02B2025-12-31: 1.05B1.05B
2021-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-311.05B+2.5%2026-03-25, From 2025-01-01
2024-12-311.02B+16.6%2026-03-25, From 2024-01-01
2023-12-31876.09M+21.0%2025-03-31, From 2023-01-01
2022-12-31723.95M+82.8%2023-04-10, From 2022-01-01
2021-12-31396.09Mn/a2023-04-10, From 2021-01-01